PAULA JONES: Open Payments
NPI 1790709756 · RINCON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 18 payments from 12 companies in 2025. Trend: 2023 $266 · 2024 $696 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $150 |
| Dexcom, Inc. | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Novo Nordisk Inc | 2 | $34 |
| ABBVIE INC. | 1 | $25 |
| PFIZER INC. | 1 | $25 |
| Abbott Laboratories | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
| Amgen Inc. | 1 | $15 |
Products named: Veozah, Dexcom G6 Transmitter, CAPLYTA, Wegovy, UBRELVY, ABRYSVO, FREESTYLE LIBRE 3, INSPIRE.
Industry payments across GA — which companies pay providers there.
